In today’s recent session, 0.46 million shares of the Eterna Therapeutics Inc (NASDAQ:ERNA) have been traded, and its beta is 4.27. Most recently the company’s share price was $0.35, and it changed around -$0.05 or -12.73% from the last close, which brings the market valuation of the company to $22.62M. ERNA at last check was trading at a discount to its 52-week high of $2.62, offering almost -648.57% off that amount. The share price’s 52-week low was $0.27, which indicates that the recent value has risen by an impressive 22.86% since then. We note from Eterna Therapeutics Inc’s average daily trading volume that its 10-day average is 3.64 million shares, with the 3-month average coming to 639.01K.
Eterna Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended ERNA as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Eterna Therapeutics Inc is expected to report earnings per share of 0 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Eterna Therapeutics Inc (NASDAQ:ERNA) trade information
Instantly ERNA has been showing red trend so far today with a performance of -12.73% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.4988 on recent trading dayincreased the stock’s daily price by 29.83%. The company’s shares are currently down -80.56% year-to-date, but still down -12.71% over the last five days. On the other hand, Eterna Therapeutics Inc (NASDAQ:ERNA) is -67.69% down in the 30-day period. We can see from the shorts that 44458.0 shares have been sold at a short interest cover period of 1.07 day(s).
Eterna Therapeutics Inc (NASDAQ:ERNA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 336.35% of Eterna Therapeutics Inc shares, and 11.00% of them are in the hands of institutional investors. The stock currently has a share float of -4.65%.
Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024. The former held 26.1 shares worth $8938.0, making up 0.05% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 13.34 shares worth around $4569.0, which represents about 0.03% of the total shares outstanding.
